Mode
Text Size
Log in / Sign up
N/A Completed N=66 Randomized Triple-blind Supportive Care

The ConnectedCancerCare Pilot Study (CCC)

Early-Stage Breast Cancer · Breast Cancer Female · Survivorship · Cancer Survivors
Source: ClinicalTrials.gov NCT03618017 ↗
Enrolled (actual)
66
Serious AEs
0.0%
Results posted
Nov 2020
Primary outcomePrimary: Number of Breast Cancer Patients Successfully Recruited to Participate in the Study — 66 Participants

Summary

This study is an NCI-funded, randomized control pilot trial to evaluate: (1) the feasibility and acceptability of a web-based, personalized navigation tool (ConnectedCancerCare) and (2) explore whether the tool improves delivery of team-based survivorship care for women who have recently finished primary breast cancer treatment.

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Breast Cancer Patients Successfully Recruited to Participate in the Study
66
SECONDARY
Rating the Experience With the CCC Web-based, Survivorship Care Plan
4.4
SECONDARY
Percentage of Patients Reporting a Preference for an Oncologist vs. PCP for Their Continuing Cancer Care Services
0; 3; 5; 14; 23; 25
SECONDARY
Percentage of Patients Scheduling a Primary Care Physician (PCP) Appointment
11; 18
SECONDARY
Patient-Reported Satisfaction With Oncologist/PCP Coordination of Care
3.1; 3.7
SECONDARY
Percentage of Patients That Communicated With PCP About Provider Roles
2; 12
SECONDARY
Knowledge About Team-based Survivorship Care
3.4; 3.7

Eligibility Criteria

Inclusion Criteria

  • Diagnosed with early Stage (0-IIB) breast cancer
  • Must be a patient of a University of Michigan Breast Cancer Oncologist
  • Must be completing primary cancer treatment and transitioning into survivorship
  • Must be able to speak, read and write in English
  • Must have access and the ability to use the internet

Exclusion Criteria

  • Diagnosed with stage III or IV breast cancer
  • Unable to speak, read, and write in English
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03618017). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search